A Randomized Control Open Label Clinical Trial On The Efficacy Of Shatapushpa Churna And Madhutailika Basti In Nashtartava w.s.r. To Polycystic Ovarian Syndrome

ational Institute of Ayurveda Jaipur0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients willing to give voluntary informed consent.
•Both married and unmarried patients.
•ASRM/ESHRE (Rotterdam) Criteria,2013- Affected individuals must have two out of three criteria
•1. Oligo and /or anovulation
•2. Hyperandrogenism (clinical and /or biochemical).
•3. Polycystic ovaries(Confirmed on USG).

•Patients not willing to give voluntary informed consent.
•Women of age <18years and >40years.
•Patients with chronic systemic illness (Congestive cardiac failure, Hypertension, cirrhosis of liver, chronic renal disease, diabetes mellitus, Tuberculosis etc.).
•Patients using oral contraceptive pills.
•Patients with any organic reproductive system abnormalities (Excluded clinically and radiologically), pelvic inflammatory disease, hydrosalpinx, endometriosis, adenomyosis, fibroid uterus, carcinoma of reproductive organ.
•Any type of malignancy.
•Patients with positive Sexually transmitted diseases (STDs), Human Immunodeficiency Virus HIV, Hepatitis B Surface Antigen(HbsAg).
•Patients suffering from adrenal hyperplasia, severe insulin resistance, androgen secreting neoplasm, thyroid abnormalities, Cushingâ??s syndrome.

发起方

ational Institute of Ayurveda Jaipur